Socioeconomic status and disability progression in multiple sclerosis A multinational study

被引:54
|
作者
Harding, Katharine E. [1 ,2 ,3 ]
Wardle, Mark [4 ]
Carruthers, Robert [1 ,2 ]
Robertson, Neil [3 ,4 ]
Zhu, Feng [1 ,2 ]
Kingwell, Elaine [1 ,2 ]
Tremlett, Helen [1 ,2 ]
机构
[1] Univ British Columbia, Fac Med Neurol, Vancouver, BC, Canada
[2] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada
[3] Cardiff Univ, Univ Hosp Cardiff, Inst Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales
[4] Univ Hosp Wales, Helen Durham Ctr Neuroinflammatory Dis, Dept Neurol, Heath Pk, Cardiff, S Glam, Wales
关键词
NATURAL-HISTORY; DEPRIVATION; MORTALITY; SMOKING; RISK; COMORBIDITY; EDUCATION; GRADIENT; DISEASE; LEVEL;
D O I
10.1212/WNL.0000000000007190
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To examine the association between socioeconomic status (SES) and disability outcomes and progression in multiple sclerosis (MS). Methods Health administrative and MS clinical data were linked for 2 cohorts of patients with MS in British Columbia (Canada) and South East Wales (UK). SES was measured at MS symptom onset (+/- 3 years) based on neighborhood-level average income. The association between SES at MS onset and sustained and confirmed Expanded Disability Status Scale (EDSS) 6.0 and 4.0 and onset of secondary progression of MS (SPMS) were assessed using Cox proportional hazards models. EDSS scores were also examined via linear regression, using generalized estimating equations (GEE) with an exchangeable working correlation. Models were adjusted for onset age, sex, initial disease course, and disease-modifying drug exposure. Random effect models (meta-analysis) were used to combine results from the 2 cohorts. Results A total of 3,113 patients with MS were included (2,069 from Canada; 1,044 from Wales). A higher SES was associated with a lower hazard of reaching EDSS 6.0 (adjusted hazard ratio [aHR] 0.90, 95% confidence interval [CI] 0.89-0.91), EDSS 4.0 (aHR 0.93, 0.88-0.98), and SPMS (aHR 0.94, 0.88-0.99). The direction of findings was similar when all EDSS scores were included (GEE: beta = -0.13, -0.18 to -0.08). Conclusions Lower neighborhood-level SES was associated with a higher risk of disability progression. Reasons for this association are likely to be complex but could include factors amenable to modification, such as lifestyle or comorbidity. Our findings are relevant for planning and development of MS services.
引用
收藏
页码:E1497 / E1506
页数:10
相关论文
共 50 条
  • [31] Impact of comorbidities on the disability progression in multiple sclerosis
    Maric, Gorica
    Pekmezovic, Tatjana
    Tamas, Olivera
    Veselinovic, Nikola
    Jovanovic, Aleksa
    Lalic, Katarina
    Mesaros, Sarlota
    Drulovic, Jelena
    ACTA NEUROLOGICA SCANDINAVICA, 2022, 145 (01): : 24 - 29
  • [32] Drug Slows Disability Progression in Multiple Sclerosis
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (20): : 2069 - 2069
  • [33] Smoking Cessation and the Reduction of Disability Progression in Multiple Sclerosis: A Cohort Study
    Tanasescu, Radu
    Constantinescu, Cris S.
    Tench, Christopher R.
    Manouchehrinia, Ali
    NICOTINE & TOBACCO RESEARCH, 2018, 20 (05) : 589 - 595
  • [34] Deciphering multiple sclerosis disability progression in the elderly: a multicenter cohort study
    Ouallet, J. -C.
    Rollot, F.
    Casey, R.
    Edan, G.
    Vukusic, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 450 - 450
  • [35] What is the impact of socioeconomic status on multiple sclerosis?
    Conway, Devon S.
    NEUROLOGY, 2019, 92 (13) : E1536 - E1539
  • [36] Association of Socioeconomic Status with Osteoarthritis-Induced Disability Progression
    Narayanan, Divya
    Cleveland, Rebecca J.
    Jordan, Joanne M.
    Seaberg, Eric
    Callahan, Leigh F.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [37] The effects of natalizumab on disability progression in the AFFIRM study: correlation between changes in Multiple Sclerosis Functional Composite and Expanded Disability Status Scale scores
    Lublin, FD
    O'Connor, PW
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, DH
    Phillips, JT
    Polman, CH
    Giovannoni, G
    Wajgt, A
    Lynn, F
    Panzara, MA
    Sandrock, AW
    MULTIPLE SCLEROSIS, 2005, 11 : S152 - S153
  • [38] Blood adipokines and their association to disability status and progression index in multiple sclerosis: A three-year follow up study
    Natarajan, Renuka
    Mari, Hamalainen
    Minna, Raunio
    Moilanen, Eeva
    Elovaara, Irina
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 17 - 17
  • [39] Effectiveness of Ocrelizumab on Disease Progression and Disability Status in Multiple Sclerosis Patients: A Two-Year Prospective Cohort Study
    Schuldesz, Amanda Claudia
    Tudor, Raluca
    Cornea, Amalia
    Geni, Dorina Nicola
    Lata, Irina Nicoleta
    Simu, Mihaela
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [40] Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areas
    Bovis, Francesca
    Signori, Alessio
    Carmisciano, Luca
    Maietta, Ilaria
    Steinerman, Joshua R.
    Li, Thomas
    Tansy, Aaron P.
    Sormani, Maria Pia
    ANNALS OF NEUROLOGY, 2018, 84 (04) : 621 - 625